Takeda Officer Andrew Stewart Plump Files Form 144 for $2.15M Proposed Share Sale
TAKEDA PHARMACEUTICAL CO LTD
Subscribe to track TAK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 Form 144 Notice of Proposed Sale: Takeda Pharmaceutical Co Ltd ($TAK)
• Insider: Andrew Stewart Plump (Officer) • Proposed Sale: 116,191 Common Shares (~$2,148,372.09) • Approx. Sale Date: September 2, 2026 • Trading Plan: Rule 10b5-1 adopted May 15, 2026 • Broker: Fidelity Brokerage Services LLC • Entity: Andrew S Plump 2020 Rev Tr U/A 12/2/20
Comprehensive Analysis
Executive Summary
On September 2, 2026, Andrew Stewart Plump, an Officer at Takeda Pharmaceutical Co Ltd ($TAK), filed a Form 144 notice of proposed sale covering 116,191 common shares with an estimated aggregate market value of $2,148,372.09 (approximately $18.49 per share).
Key Details
- Filer: Andrew Stewart Plump (Officer)
- Security: Common Stock
- Number of Shares to be Sold: 116,191
- Aggregate Value: $2,148,372.09
- Broker: Fidelity Brokerage Services LLC
- Shares Outstanding: 1,579,836,830
- Ownership Entity: The shares are being sold from the Andrew S Plump 2020 Rev Tr U/A 12/2/20.
- Origin of Shares: Originally acquired on August 20, 2020, via RSU and PSU vesting from the issuer.
- Pre-Arranged Trading Plan: The proposed sale is executed pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2026.
- Prior Transactions: The filer previously sold 19,651 shares on August 19, 2026, for gross proceeds of $363,348.49.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.